Trial intelligence / Profile preview

Baclofen Effects on Brain and Behavior in Cigarette Smokers

NCT01821560Phase 2Completed

Sponsor
University of Pennsylvania
Start
Mar 2013
Primary completion
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of baclofen in nicotine dependence, sponsored by University of Pennsylvania. Started Mar 2013; status: completed.

02

Drugs

baclofen
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT01821560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01821560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call